{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:05:53Z","timestamp":1793127953495,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010095","name":"R\u00e9gion Hauts-de-France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010095","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ARC"},{"name":"INCA"},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015872","name":"Universit\u00e9 de Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015872","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Acute myeloid leukemia (AML) remains a high-risk hematologic malignancy due to frequent relapse and therapeutic resistance. Although induction therapy can achieve cytological remission, a fraction of leukemic cells (minimal residual disease, MRD) persists within the protective bone marrow (BM) microenvironment. MRD is heterogeneous and may include subclones with intrinsic survival features present before therapy. Among these, rare BM-resident leukemic cells (BMresLC) may represent pre-adapted precursors of MRD, maintained in a low-proliferative (Ki67\n                      <jats:sup>low<\/jats:sup>\n                      ) or quiescent state. We previously showed that calcium signaling through ORAI1-dependent store-operated calcium entry (SOCE) contributes not only to AML stemness and drug resistance but also to the regulation of the G0-G1 cell-cycle transition and the emergence of slow-cycling leukemic cells. With this study, we have characterized the stemness and calcium signature of BMresLC before any therapeutic intervention. Our results, beyond further characterizing a population of cells rarely studied, could thus pave the way to new therapeutic opportunities combining current treatments with the targeting of relevant pathways highlighted by our work.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A patient-derived xenograft (PDX) model in NSG (NOD\/SCID\/IL2R\u03b3\n                      <jats:sup>null<\/jats:sup>\n                      ) mice was used to localize, isolate, and characterize human BMresLC. Whole-bone clearing and 3D-Imaris imaging enabled spatial localization of rare leukemic cells. Flow cytometry and qPCR assessed cell-cycle status, immunophenotype (CD34, CD38, TIM-3, PD-L1, Ki67), stemness, and calcium-signaling components (\n                      <jats:italic>ORAI1-3<\/jats:italic>\n                      ,\n                      <jats:italic>STIM1-2<\/jats:italic>\n                      ,\n                      <jats:italic>NFATc1-4<\/jats:italic>\n                      ). SOCE was measured using Indo-1 assays. Comparative analyses were performed against diagnostic AML cells, public MRD RNA-seq datasets, and prognosis-stratified patient cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      BMresLC displayed an immune-evasive immunophenotype and contained a small fraction of Ki67\n                      <jats:sup>neg<\/jats:sup>\n                      quiescent cells, but were not enriched in fully quiescent cells. Instead, they predominantly exhibited a Ki67\n                      <jats:sup>low<\/jats:sup>\n                      slow-cycling profile, consistent with a low-proliferative persistent state. Transcriptional analysis revealed overexpression of stemness-associated genes and selective downregulation of calcium-signaling components\n                      <jats:italic>ORAI1, ORAI2, STIM2<\/jats:italic>\n                      , and\n                      <jats:italic>NFATc1\/c4<\/jats:italic>\n                      , consistent with a SOCE-suppressed calcium signature. Functional assays confirmed reduced calcium influx. Compared with post-therapy MRD datasets, BMresLC showed some stemness and immune-evasion traits but displayed a distinct pre-therapeutic calcium signature, suggesting that it represents an early, persistent state preceding full MRD remodeling. Prognostic subgroup analysis further showed that BMresLC calcium and stemness profiles partially recapitulate features of adverse-risk AML, including differences in CD34, CD38, PD-L1,\n                      <jats:italic>MMRN1<\/jats:italic>\n                      ,\n                      <jats:italic>LAPTM4B<\/jats:italic>\n                      ,\n                      <jats:italic>NFATc2<\/jats:italic>\n                      , and\n                      <jats:italic>STIM2<\/jats:italic>\n                      expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings identify a distinctive calcium- and stemness-based signature in BMresLC, representing a pre-MRD survival state characterized by slow cycling rather than enrichment in strict quiescence. This pre-therapeutic signature may contribute to MRD establishment and relapse risk in AML.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03634-x","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:44:23Z","timestamp":1767926663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pre-therapeutic bone marrow-resident leukemic cells in acute myeloid leukemia exhibit a distinct dysregulated calcium signature and stem-like profile reflecting minimal residual disease precursors"],"prefix":"10.1186","volume":"45","author":[{"given":"Sofia","family":"Titah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Guillemette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Lewuillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruk Azam","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Berthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Goursaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Tardivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Bongiovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Chauvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Jouy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Peyrouze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meyling","family":"Cheok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Brinster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon","family":"Manier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet \u00c7agatay","family":"Tarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Lemonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Quesnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Touil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"12","key":"3634_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"issue":"7","key":"3634_CR2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/nm.4125","volume":"22","author":"S Li","year":"2016","unstructured":"Li S, Garrett-Bakelman FE, Chung SS, Sanders MA, Hricik T, Rapaport F, et al. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia. Nat Med. 2016;22(7):792\u20139.","journal-title":"Nat Med"},{"issue":"6","key":"3634_CR3","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/leu.2011.383","volume":"26","author":"C Bachas","year":"2012","unstructured":"Bachas C, Schuurhuis GJ, Assaraf YG, Kwidama ZJ, Kelder A, Wouters F, et al. The role of minor subpopulations within the leukemic blast compartment of AML patients at initial diagnosis in the development of relapse. Leukemia. 2012;26(6):1313\u201320.","journal-title":"Leukemia"},{"issue":"7728","key":"3634_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner JW. Functional genomics reveals therapeutic targets in AML. Nature. 2018;562(7728):526\u201331.","journal-title":"Nature"},{"issue":"7","key":"3634_CR5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41408-022-00707-4","volume":"12","author":"S Tettamanti","year":"2022","unstructured":"Tettamanti S. Genetic and epigenetic basis of minimal residual disease in AML. Blood Cancer J. 2022;12(7):113\u201321.","journal-title":"Blood Cancer J"},{"issue":"7488","key":"3634_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature13038","volume":"506","author":"LI Shlush","year":"2014","unstructured":"Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506(7488):328\u201333.","journal-title":"Nature"},{"issue":"2","key":"3634_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica. 2023;108(2):353\u201366.","journal-title":"Haematologica"},{"issue":"7","key":"3634_CR8","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge T, Saland E, de Toni F, Aroua N, Hosseini M, Perry R, et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 2017;7(7):716\u201335.","journal-title":"Cancer Discov"},{"issue":"1","key":"3634_CR9","doi-asserted-by":"publisher","first-page":"20119","DOI":"10.1038\/s41598-020-76933-2","volume":"10","author":"T Kim","year":"2020","unstructured":"Kim T, Moon JH, Ahn JS, Ahn SY, Jung SH, Yang DH, et al. RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia. Sci Rep. 2020;10(1):20119.","journal-title":"Sci Rep"},{"key":"3634_CR10","doi-asserted-by":"publisher","first-page":"764698","DOI":"10.3389\/fcell.2021.764698","volume":"9","author":"DB Pimenta","year":"2021","unstructured":"Pimenta DB, Varela VA, Datoguia TS, Caraciolo VB, Lopes GH, Pereira WO. The bone marrow microenvironment mechanisms in acute myeloid leukemia. Front Cell Dev Biol. 2021;9:764698.","journal-title":"Front Cell Dev Biol"},{"key":"3634_CR11","doi-asserted-by":"crossref","unstructured":"Lewuillon C, Laguillaumie MO, Quesnel B, Idziorek T, Touil Y, Lemonnier L. Put in a \"Ca(2+)ll\" to Acute Myeloid Leukemia. Cells. 2022;11(3).","DOI":"10.3390\/cells11030543"},{"key":"3634_CR12","doi-asserted-by":"publisher","first-page":"103066","DOI":"10.1016\/j.ceca.2025.103066","volume":"131","author":"M Robitaille","year":"2025","unstructured":"Robitaille M. Protein diversity in store-operated calcium entry components and their related variants. Cell Calcium. 2025;131:103066.","journal-title":"Cell Calcium"},{"issue":"8","key":"3634_CR13","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1113\/JP283828","volume":"602","author":"M Sallinger","year":"2024","unstructured":"Sallinger M, Grabmayr H, Humer C, Bonhenry D, Romanin C, Schindl R, et al. Activation mechanisms and structural dynamics of STIM proteins. J Physiol. 2024;602(8):1475\u2013507.","journal-title":"J Physiol"},{"issue":"1","key":"3634_CR14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13046-021-02046-x","volume":"40","author":"M Mancini","year":"2021","unstructured":"Mancini M. Targeting the calcineurin\u2013NFAT pathway in AML. J Exp Clin Cancer Res. 2021;40(1):251\u201363.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"3634_CR15","first-page":"374","volume":"18","author":"M Vaeth","year":"2017","unstructured":"Vaeth M. Store-operated Ca2+ entry controls T cell effector functions. Nat Immunol. 2017;18(3):374\u201382.","journal-title":"Nat Immunol"},{"issue":"4","key":"3634_CR16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/jcp.30971","volume":"238","author":"J Nieto-Felipe","year":"2023","unstructured":"Nieto-Felipe J, Macias-Diaz A, Sanchez-Collado J, Berna-Erro A, Jardin I, Salido GM, et al. Role of Orai-family channels in the activation and regulation of transcriptional activity. J Cell Physiol. 2023;238(4):714\u201326.","journal-title":"J Cell Physiol"},{"issue":"5","key":"3634_CR17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41590-020-0667-8","volume":"21","author":"M Vaeth","year":"2020","unstructured":"Vaeth M. NFAT as a central integrator of Ca2+ signaling in lymphocytes. Nat Immunol. 2020;21(5):495\u2013502.","journal-title":"Nat Immunol"},{"issue":"8","key":"3634_CR18","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1084\/jem.20180421","volume":"215","author":"T Umemoto","year":"2018","unstructured":"Umemoto T. Ca2+-mitochondria axis drives cell division in hematopoietic stem cells. J Exp Med. 2018;215(8):2097\u2013113.","journal-title":"J Exp Med"},{"issue":"7754","key":"3634_CR19","first-page":"439","volume":"569","author":"LL Luchsinger","year":"2019","unstructured":"Luchsinger LL. Mitofusin 2 maintains hematopoietic stem cells with extensive lymphoid potential. Nature. 2019;569(7754):439\u201343.","journal-title":"Nature"},{"issue":"3","key":"3634_CR20","first-page":"493","volume":"28","author":"MD Filippi","year":"2021","unstructured":"Filippi MD. Mitochondrial calcium uptake drives hematopoietic stem cell division. Cell Stem Cell. 2021;28(3):493\u2013508.","journal-title":"Cell Stem Cell"},{"key":"3634_CR21","doi-asserted-by":"publisher","unstructured":"Lewuillon C, Guillemette A, Titah S, Shaik FA, Jouy N, Labiad O, Farfariello V, Laguillaumie MO, Idziorek T, Barth\u00e9\u00e9l\u00e9\u00e9my A, Peyrouze P, Berthon C, Tarhan MC, Cheok M, Quesnel B, Lemonnier L, Touil Y. Involvement of ORAI1\/SOCE in Human AML Cell Lines and Primary Cells According to ABCB1 Activity, LSC Compartment and Potential Resistance to Ara-C Exposure. Int J Mol Sci. 2022 May 16;23(10):5555. https:\/\/doi.org\/10.3390\/ijms23105555. PMID: 35628366; PMCID: PMC9141756.","DOI":"10.3390\/ijms23105555"},{"key":"3634_CR22","doi-asserted-by":"publisher","unstructured":"Boyer T, Gonzales F, Plesa A, Peyrouze P, Barthelemy A, Guihard S, Quesnel B, Roumier C, Preudhomme C, Cheok M. Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient derived-xenografts, at Diagnosis and Follow Up. J Vis Exp. 2018 Mar 26;(133):56976. https:\/\/doi.org\/10.3791\/56976. PMID: 29630051; PMCID: PMC5933244.","DOI":"10.3791\/56976"},{"issue":"7728","key":"3634_CR23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner JW, Tognon CE, Bottomly D, Wilmot B, Kurtz SE, Savage SL, et al. Functional genomic landscape of acute myeloid leukaemia. Nature. 2018;562(7728):526\u201331.","journal-title":"Nature"},{"issue":"8","key":"3634_CR24","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","volume":"40","author":"D Bottomly","year":"2022","unstructured":"Bottomly D, Long N, Schultz AR, Kurtz SE, Tognon CE, Johnson K, et al. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia. Cancer Cell. 2022;40(8):850-864.e859.","journal-title":"Cancer Cell"},{"issue":"5","key":"3634_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"1","key":"3634_CR26","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41467-023-36969-0","volume":"14","author":"MM Naldini","year":"2023","unstructured":"Naldini MM, Casirati G, Barcella M, Rancoita PMV, Cosentino A, Caserta C, et al. Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia. Nat Commun. 2023;14(1):1285.","journal-title":"Nat Commun"},{"issue":"3","key":"3634_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1607","volume":"28","author":"Y Saito","year":"2010","unstructured":"Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, Sone A, et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol. 2010;28(3):275\u201380.","journal-title":"Nat Biotechnol"},{"issue":"7633","key":"3634_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SWK Ng","year":"2016","unstructured":"Ng SWK, Mitchell A, Kennedy JA, Chen WC, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540(7633):433\u20137.","journal-title":"Nature"},{"issue":"7483","key":"3634_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12984","volume":"505","author":"SJ Morrison","year":"2014","unstructured":"Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505(7483):327\u201334.","journal-title":"Nature"},{"issue":"3","key":"3634_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.stem.2015.02.014","volume":"16","author":"K Schepers","year":"2015","unstructured":"Schepers K, Campbell TB, Passegu\u00e9 E. Normal and leukemic stem cell niches: insights and therapeutic opportunities. Cell Stem Cell. 2015;16(3):254\u201367.","journal-title":"Cell Stem Cell"},{"issue":"7473","key":"3634_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature12612","volume":"502","author":"Y Kunisaki","year":"2013","unstructured":"Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013;502(7473):637\u201343.","journal-title":"Nature"},{"issue":"7","key":"3634_CR32","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge T, et al. Chemotherapy-resistant human AML cells are not enriched for LSCs but require oxidative metabolism. Cancer Discov. 2017;7(7):716\u201335.","journal-title":"Cancer Discov"},{"issue":"4","key":"3634_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00018-016-2306-y","volume":"74","author":"A S\u00e1nchez-Aguilera","year":"2017","unstructured":"S\u00e1nchez-Aguilera A, M\u00e9ndez-Ferrer S. The hematopoietic stem-cell niche in health and leukemia. Cell Mol Life Sci. 2017;74(4):579\u201390.","journal-title":"Cell Mol Life Sci"},{"issue":"14","key":"3634_CR34","first-page":"1570","volume":"136","author":"TC Ho","year":"2020","unstructured":"Ho TC. Leukemic stem cells as therapeutic targets in AML. Blood. 2020;136(14):1570\u201380.","journal-title":"Blood"},{"key":"3634_CR35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.stem.2010.11.014","volume":"7","author":"Y Kikushige","year":"2010","unstructured":"Kikushige Y, et al. TIM-3 is a functional marker and potential therapeutic target for human AML stem cells. Cell Stem Cell. 2010;7:83\u201394.","journal-title":"Cell Stem Cell"},{"key":"3634_CR36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fimmu.2020.00508","volume":"11","author":"L Lanikova","year":"2020","unstructured":"Lanikova L, et al. Immune checkpoints regulate AML stem cells. Front Immunol. 2020;11:508.","journal-title":"Front Immunol"},{"issue":"12","key":"3634_CR37","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00262-010-0909-y","volume":"59","author":"C Berthon","year":"2010","unstructured":"Berthon C, Driss V, Liu J, Kuranda K, Leleu X, Jouy N, et al. In acute myeloid leukemia, B7\u2013H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. Cancer Immunol Immunother. 2010;59(12):1839\u201349.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"3634_CR38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/leu.2015.214","volume":"30","author":"C Krupka","year":"2016","unstructured":"Krupka C, Kufer P, Kischel R, Zugmaier G, Lichtenegger FS, K\u00f6hnke T, et al. Blockade of the PD-1\/PD-L1 axis augments lysis of AML cells by the CD33\/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism. Leukemia. 2016;30(2):484\u201391.","journal-title":"Leukemia"},{"issue":"4","key":"3634_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11912-019-0781-7","volume":"21","author":"M Stahl","year":"2019","unstructured":"Stahl M, Goldberg AD. Immune checkpoint inhibitors in acute myeloid leukemia: novel combinations and therapeutic targets. Curr Oncol Rep. 2019;21(4):37.","journal-title":"Curr Oncol Rep"},{"issue":"12","key":"3634_CR40","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.cub.2014.04.046","volume":"24","author":"P Kar","year":"2014","unstructured":"Kar P, Samanta K, Kramer H, Morris O, Bakowski D, Parekh AB. Dynamic assembly of a membrane signaling complex enables selective activation of NFAT by Orai1. Current biology\u202f: CB. 2014;24(12):1361\u20138.","journal-title":"Current biology : CB"},{"issue":"3","key":"3634_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/hemato2030035","volume":"2","author":"SD Patterson","year":"2021","unstructured":"Patterson SD, Huang X, J\u00f8rgensen HG, Michie AM. Transcriptional regulation by the NFAT family in acute myeloid leukaemia. Hemato. 2021;2(3):556\u201371.","journal-title":"Hemato"},{"issue":"5","key":"3634_CR42","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S1097-2765(02)00701-3","volume":"10","author":"S Baksh","year":"2002","unstructured":"Baksh S, Widlund HR, Frazer-Abel AA, Du J, Fosmire S, Fisher DE, et al. NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell. 2002;10(5):1071\u201381.","journal-title":"Mol Cell"},{"issue":"6","key":"3634_CR43","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.bbamcr.2016.11.014","volume":"1864","author":"R Diez-Bello","year":"2017","unstructured":"Diez-Bello R, Jardin I, Salido GM, Rosado JA. Orai1 and Orai2 mediate store-operated calcium entry that regulates HL60 cell migration and FAK phosphorylation. Biochim Biophys Acta Mol Cell Res. 2017;1864(6):1064\u201370.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3634_CR44","doi-asserted-by":"crossref","unstructured":"Fahrner M, Schindl R, Romanin C. Studies of Structure-Function and Subunit Composition of Orai\/STIM Channel. In: Calcium Entry Channels in Non-Excitable Cells. Edited by Kozak JA, Putney JW. Boca Raton (FL): CRC Press\/Taylor & Francis; 2018.","DOI":"10.1201\/9781315152592-2"},{"issue":"1","key":"3634_CR45","first-page":"118610","volume":"1867","author":"H Ayadi","year":"2020","unstructured":"Ayadi H. ORAI3 silencing alters cell proliferation and cell cycle progression in prostate cancer cells. Biochim Biophys Acta Mol Cell Res. 2020;1867(1):118610.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"11","key":"3634_CR46","first-page":"9734","volume":"9","author":"WT Berry","year":"2018","unstructured":"Berry WT. Orai3-mediated Ca2+ entry supports breast cancer cell resistance to oxidative stress. Oncotarget. 2018;9(11):9734\u201348.","journal-title":"Oncotarget"},{"key":"3634_CR47","doi-asserted-by":"publisher","unstructured":"Dubois C, Kondratska K, Kondratskyi A, Morabito A, Mesilmany L, Farfariello V, Toillon RA, Ziental Gelus N, Laurenge E, Vanden Abeele F, Lemonnier L, Prevarskaya N. ORAI3 silencing alters cell proliferation and promotes mitotic catastrophe and apoptosis in pancreatic adenocarcinoma. Biochim BiophysActa Mol Cell Res. 2021 Jun;1868;(7):119023. https:\/\/doi.org\/10.1016\/j.bbamcr.2021.119023. Epub 2021Mar 30. PMID: 33798603.","DOI":"10.1016\/j.bbamcr.2021.119023"},{"key":"3634_CR48","doi-asserted-by":"crossref","unstructured":"Groschner K, Shrestha N, Fameli N. Non-Orai Partners of STIM Proteins: Role in ER-PM Communication and Ca2+ Signaling. In: Calcium Entry Channels in Non-Excitable Cells. Edited by Kozak JA, Putney JW. Boca Raton (FL): CRC Press\/Taylor & Francis; 2018.","DOI":"10.1201\/9781315152592-10"},{"issue":"13","key":"3634_CR49","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.cub.2005.05.055","volume":"15","author":"J Liou","year":"2005","unstructured":"Liou J, Kim ML, Heo WD, Jones JT, Myers JW, Ferrell JE Jr., et al. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol. 2005;15(13):1235\u201341.","journal-title":"Curr Biol"},{"issue":"30","key":"3634_CR50","doi-asserted-by":"publisher","first-page":"20661","DOI":"10.1074\/jbc.C600126200","volume":"281","author":"J Soboloff","year":"2006","unstructured":"Soboloff J, Spassova MA, Tang XD, Hewavitharana T, Xu W, Gill DL. Orai1 and STIM reconstitute store-operated calcium channel function. J Biol Chem. 2006;281(30):20661\u20135.","journal-title":"J Biol Chem"},{"issue":"18","key":"3634_CR51","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1073\/pnas.0900293106","volume":"106","author":"Y Wang","year":"2009","unstructured":"Wang Y, Deng X, Zhou Y, Hendron E, Mancarella S, Ritchie MF, et al. Stim protein coupling in the activation of Orai channels. Proc Natl Acad Sci U S A. 2009;106(18):7391\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3634_CR52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13045-021-01084-4","volume":"14","author":"A Janssens","year":"2021","unstructured":"Janssens A, et al. NFATc2 Activation in AML Relapse. J Hematol Oncol. 2021;14:75.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"3634_CR53","doi-asserted-by":"publisher","first-page":"108327","DOI":"10.1016\/j.celrep.2020.108327","volume":"33","author":"L Wu","year":"2020","unstructured":"Wu L, Lin W, Liao Q, Wang H, Lin C, Tang L, et al. Calcium channel blocker nifedipine suppresses colorectal cancer progression and immune escape by preventing NFAT2 nuclear translocation. Cell Rep. 2020;33(4):108327.","journal-title":"Cell Rep"},{"issue":"2","key":"3634_CR54","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0171-2985(00)80060-1","volume":"202","author":"S Feske","year":"2000","unstructured":"Feske S, Draeger R, Peter HH, Rao A. Impaired NFAT regulation and its role in a severe combined immunodeficiency. Immunobiology. 2000;202(2):134\u201350.","journal-title":"Immunobiology"},{"issue":"4","key":"3634_CR55","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/86318","volume":"2","author":"S Feske","year":"2001","unstructured":"Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A. Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol. 2001;2(4):316\u201324.","journal-title":"Nat Immunol"},{"issue":"1","key":"3634_CR56","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1038\/s41467-023-41770-0","volume":"14","author":"RS Pereira","year":"2023","unstructured":"Pereira RS, Kumar R, Cais A, Paulini L, Kahler A, Bravo J, et al. Distinct and targetable role of calcium-sensing receptor in leukaemia. Nat Commun. 2023;14(1):6242.","journal-title":"Nat Commun"},{"issue":"1","key":"3634_CR57","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41467-022-27973-x","volume":"13","author":"SA Yeh","year":"2022","unstructured":"Yeh SA, Hou J, Wu JW, Yu S, Zhang Y, Belfield KD, et al. Quantification of bone marrow interstitial pH and calcium concentration by intravital ratiometric imaging. Nat Commun. 2022;13(1):393.","journal-title":"Nat Commun"},{"issue":"7661","key":"3634_CR58","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","volume":"547","author":"LI Shlush","year":"2017","unstructured":"Shlush LI, et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature. 2017;547(7661):104\u20138.","journal-title":"Nature"},{"issue":"17","key":"3634_CR59","first-page":"2340","volume":"139","author":"W Vainchenker","year":"2022","unstructured":"Vainchenker W, Constantinescu SN. Deregulated JAK-STAT signaling in myeloproliferative neoplasms. Blood. 2022;139(17):2340\u201354.","journal-title":"Blood"},{"issue":"11","key":"3634_CR60","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/nprot.2012.119","volume":"7","author":"A Ert\u00fcrk","year":"2012","unstructured":"Ert\u00fcrk A, Becker K, J\u00e4hrling N, Mauch CP, Hojer CD, Egen JG, et al. Three-dimensional imaging of solvent-cleared organs using 3DISCO. Nat Protoc. 2012;7(11):1983\u201395.","journal-title":"Nat Protoc"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03634-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:04:17Z","timestamp":1771329857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03634-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3634"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03634-x","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were performed following European standards for the use of animals for scientific purposes, and the relevant protocol was approved by the local Ethics committee (#3097-2015120414583482v3). Race\/ethnicity information for human participants cannot be divulged in accordance with local legal constraints. All participants signed an informed consent obtained in accordance with Lille Hospital Tumor Bank (certification NF 96900 2014\/65453\u20131) for AML patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}